Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.440
-0.060 (-4.00%)
At close: Oct 29, 2024, 4:00 PM
1.560
+0.120 (8.33%)
After-hours: Oct 29, 2024, 5:56 PM EDT
Chemomab Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Oct '24 Oct 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 21 | 6 | 37 | 79 | - | - | |
| Market Cap Growth | -10.71% | -83.65% | -53.12% | - | - | - | |
| Enterprise Value | 8 | -15 | -9 | 15 | - | - | |
| Last Close Price | 1.44 | 0.51 | 3.20 | 6.90 | - | - | |
| PE Ratio | - | -0.25 | -1.32 | -5.74 | - | - | |
| PB Ratio | 2.07 | 0.35 | 1.02 | 1.28 | - | - | |
| P/FCF Ratio | -0.80 | -0.26 | -1.80 | -6.24 | - | - | |
| P/OCF Ratio | -0.80 | -0.26 | -1.81 | -6.36 | - | - | |
| EV/EBITDA Ratio | 0.16 | 0.60 | 0.33 | -1.20 | - | - | |
| EV/EBIT Ratio | 0.16 | 0.60 | 0.33 | -1.19 | - | - | |
| EV/FCF Ratio | 0.16 | 0.65 | 0.46 | -1.17 | - | - | |
| Debt / Equity Ratio | 0.04 | 0.02 | 0.01 | 0.01 | 0.04 | 0.02 | |
| Debt / FCF Ratio | -0.02 | -0.02 | -0.01 | -0.03 | -0.08 | -0.03 | |
| Quick Ratio | 3.11 | 4.15 | 5.98 | 23.15 | 8.95 | 18.81 | |
| Current Ratio | 3.12 | 4.32 | 6.18 | 23.66 | 9.00 | 18.85 | |
| Return on Equity (ROE) | -93.80% | -91.02% | -56.60% | -34.53% | -51.36% | -80.65% | |
| Return on Assets (ROA) | -46.18% | -48.80% | -33.20% | -20.12% | -29.12% | -46.48% | |
| Return on Capital (ROIC) | -61.70% | -59.12% | -36.30% | -21.16% | -31.37% | -49.81% | |
| Earnings Yield | -72.53% | -401.76% | -74.96% | -15.86% | - | - | |
| FCF Yield | -78.01% | -391.70% | -55.41% | -16.03% | - | - | |
| Buyback Yield / Dilution | -19.04% | -3.26% | -9.70% | -51.71% | - | - | |
| Total Shareholder Return | -19.04% | -3.26% | -9.70% | -51.71% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.